Zivo Bioscience, Inc. (ZIVO): Net Income

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$13.38M
Year ended 2024-12-31
-$8.49M
Trailing 12 months to 2025-09-30
$680.8K2010-12-31: -$7.12M2011-12-31: -$2.73M2012-12-31: -$3.25M2013-12-31: -$10.10M2014-12-31: $680.8K2015-12-31: -$5.79M2016-12-31: -$6.06M2017-12-31: -$10.04M2018-12-31: -$14.64M2019-12-31: -$11.51M2020-12-31: -$9.11M2021-12-31: -$8.76M2022-12-31: -$8.75M2023-12-31: -$7.78M2024-12-31: -$13.38M-$13.38M
2010-12-31 Net Income (USD) 2024-12-31
Period endedNet IncomeChange YoYSource filing
2024-12-31-$13.38Mn/m2025-03-18, From 2024-01-01
2023-12-31-$7.78Mn/m2025-03-18, From 2023-01-01
2022-12-31-$8.75Mn/m2024-03-15, From 2022-01-01
2021-12-31-$8.76Mn/c2023-03-14, From 2021-01-01
2020-12-31-$9.11Mn/m2022-04-22, From 2020-01-01
2019-12-31-$11.51Mn/m2021-02-25, From 2019-01-01
2018-12-31-$14.64Mn/m2020-03-26, From 2018-01-01
2017-12-31-$10.04Mn/m2019-02-12, From 2017-01-01
2016-12-31-$6.06Mn/m2018-02-21, From 2016-01-01
2015-12-31-$5.79Mn/m2017-03-31, From 2015-01-02
2014-12-31$680.8Kn/m2016-03-29, From 2014-01-02
2013-12-31-$10.10Mn/m2015-04-06, From 2013-01-02
2012-12-31-$3.25Mn/m2014-03-31, From 2012-01-02
2011-12-31-$2.73Mn/m2013-03-25, From 2011-01-01
2010-12-31-$7.12Mn/a2012-03-30, From 2010-01-02